Artwork
iconShare
 
Manage episode 319196853 series 2933391
Content provided by SciPro. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by SciPro or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In the final episode of series 2, Nick is joined by Dr.Muhunthan Thillai, the co-founder and CEO of Qureight and they discuss the innovative way they are using AI to allow for effective drug development in complex diseases. This is also a fantastic episode for understanding how founders from a medical background have built an AI company.

Dr.Muhunthan Thillai is the co-founder and CEO of Qureight, a medical technology company in Cambridge which aims to pioneer data curation in complex diseases. By structuring image and biomarker data from biopharma and healthcare institutions, Qureight uses their AI-assisted platform to look for new trial endpoints in complex diseases including Idiopathic Pulmonary Fibrosis, Lung Cancer and Pulmonary Hypertension.

To speak to Nick, please drop an email to [email protected]

  continue reading

33 episodes